Showing results (2311-2320 of 2,948) with videos related to

Sort By:
Pageof 295
BMJ (Clinical Research Ed.)|August 4, 2017
GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in researchS Staniszewska, J Brett, I Simera, et al.
Anaesthesia|November 20, 2015
Recommendations for standards of monitoring during anaesthesia and recovery 2015: Association of Anaesthetists of Great Britain and IrelandM R Checketts, R Alladi, K Ferguson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2009
Proteomic signatures of epidermal growth factor receptor and survival signal pathways correspond to gefitinib sensitivity in head and neck cancerFrancisco G Pernas, Clint T Allen, Mary E Winters, et al.
Alzheimer Disease and Associated Disorders|November 30, 2006
The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease CentersJohn C Morris, Sandra Weintraub, Helena C Chui, et al.
Neurology|April 19, 2013
Urine toxicology screening in an urban stroke and TIA populationBrian Silver, Daniel Miller, Michelle Jankowski, et al.
Frontiers in Systems Biology|August 14, 2025
Surface-displayed silicatein-α enzyme in bioengineered E. coli enables biocementation and silica mineralizationToriana N Vigil, Nikolas K Schwendeman, Melanie L M Grogger, et al.
Science Signaling|December 13, 2018
The microRNA miR-7a-5p ameliorates ischemic brain damage by repressing α-synucleinTaeHee Kim, Suresh L Mehta, Kahlilia C Morris-Blanco, et al.
The Journal of Allergy and Clinical Immunology|December 17, 2021
Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiencyLinlin Yang, Claire Booth, Carsten Speckmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 3, 2006
Preclinical and phase I clinical trial of blockade of IL-15 using Mikbeta1 monoclonal antibody in T cell large granular lymphocyte leukemiaJohn C Morris, John E Janik, Jeffrey D White, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2002
Double-blind, randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in postmenopausal women with advanced breast cancer progressing on prior endocrine therapy: results of a North American trialC K Osborne, J Pippen, S E Jones, et al.
Pageof 295